Evaluating feasibility and acceptability of a group WHO trans-diagnostic intervention for women with common mental disorders in rural Pakistan: a cluster randomised controlled feasibility trial.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7960
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 12 7 2017
medline: 13 9 2019
entrez: 11 7 2017
Statut: ppublish

Résumé

The aim of this feasibility trial was to evaluate the feasibility and acceptability of the locally adapted Group Problem Management Plus (PM+) intervention for women in the conflict affected settings in Swat, Pakistan. This mixed-methods study incorporated a quantitative component consisting of a two arm cluster randomised controlled feasibility trial, and qualitative evaluation of the acceptability of the Group PM+ to a range of stakeholder groups. For the quantitative component, on average from each of the 20 Lady Health Workers (LHWs) catchment area (20 clusters), six women were screened and recruited for the trial with score of >2 on the General Health Questionnaire and score of >16 on the WHO Disability Assessment Schedule. These LHW clusters were randomised on a 1 : 1 allocation ratio using a computer-based software through a simple randomisation method to the Group PM+ intervention or Enhanced Usual Care. The Group PM+ intervention consisted of five weekly sessions of 2 h duration delivered by local non-specialist females under supervision. The primary outcome was individual psychological distress, measured by levels of anxiety and depression on the Hospital Anxiety and Depression Scale at 7th week after baseline. Secondary outcomes include symptoms of depression, post-traumatic stress disorder (PTSD), general psychological profile, levels of functioning and generalised psychological distress. Intervention acceptability was explored through in-depth interviews. The results show that lay-helpers with no prior mental health experience can be trained to achieve the desired competency to successfully deliver the intervention in community settings under supervision. There was a good intervention uptake, with Group PM+ considered useful by participants, their families and lay-helpers. The outcome evaluation, which was not based on a large enough study to identify statistically significant results, indicated statistically significant improvements in depression, anxiety, general psychological profile and functioning. The PTSD symptoms and depressive disorder scores showed a trend in favour of the intervention. This trial showed robust acceptance in the local settings with delivery by non-specialists under supervision by local trained females. The trial paves the way for further adaptation and exploration of the outcomes through larger-scale implementation and definitive randomised controlled trials in the local settings.

Identifiants

pubmed: 28689511
pii: S2045796017000336
doi: 10.1017/S2045796017000336
pmc: PMC6998939
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-87

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : ErratumIn

Références

Lancet. 2009 Jul 4;374(9683):23
pubmed: 19577683
Asia Pac Psychiatry. 2012 Jun;4(2):104-12
pubmed: 26767354
Bull World Health Organ. 2015 Oct 1;93(10):666-666A
pubmed: 26600604
Lancet. 2008 Apr 5;371(9619):1165-72
pubmed: 18395577
Acta Psychiatr Scand. 1991 Feb;83(2):81-5
pubmed: 2017915
PLoS One. 2009 Dec 17;4(12):e8343
pubmed: 20020047
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Lancet. 2011 Nov 5;378(9803):1654-63
pubmed: 22008420
J Psychiatr Res. 2011 May;45(5):626-9
pubmed: 21035130
Behav Res Ther. 2008 Feb;46(2):163-73
pubmed: 18199423
Am J Public Health. 1996 Nov;86(11):1561-9
pubmed: 8916521
Lancet. 2008 Sep 13;372(9642):902-9
pubmed: 18790313
JAMA. 2009 Aug 5;302(5):537-49
pubmed: 19654388
J Pak Med Assoc. 2011 Mar;61(3):210-5
pubmed: 21465929
Bull World Health Organ. 2013 Aug 1;91(8):593-601I
pubmed: 23940407
Lancet. 2011 Oct 29;378(9802):1581-91
pubmed: 22008428
Int J Methods Psychiatr Res. 2010 Mar;19(1):1-17
pubmed: 20104493
Psychol Med. 2003 Oct;33(7):1161-7
pubmed: 14580070
Confl Health. 2015 Dec 10;9:37
pubmed: 26664447
BMC Psychiatry. 2007 Oct 26;7:59
pubmed: 17963494
J Nerv Ment Dis. 1992 Feb;180(2):111-6
pubmed: 1737972
J Affect Disord. 2014 Oct;168:452-8
pubmed: 25113958
Int J Ment Health Syst. 2011 Nov 18;5(1):30
pubmed: 22099582
Soc Psychiatry Psychiatr Epidemiol. 2003 Jan;38(1):35-43
pubmed: 12563557
JAMA. 2003 Jun 18;289(23):3117-24
pubmed: 12813117
Behav Res Ther. 2005 Apr;43(4):413-31
pubmed: 15701354
World Psychiatry. 2015 Oct;14(3):354-7
pubmed: 26407793
JAMA. 2013 Aug 7;310(5):477-8
pubmed: 23925613
Psychother Res. 2008 Mar;18(2):225-36
pubmed: 18815968
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941

Auteurs

M N Khan (MN)

Khyber Medical University,Institute of Public Health & Social Sciences (IPH&SS),10-B,Near ICMS,Phase V,Hayatabad,Peshawar,Pakistan.

S U Hamdani (SU)

Human Development Research Foundation,Islamabad,Pakistan.

A Chiumento (A)

University of Liverpool,Liverpool,UK.

K Dawson (K)

University of New South Wales,Sydney,Australia.

R A Bryant (RA)

University of New South Wales,Sydney,Australia.

M Sijbrandij (M)

VU University Amsterdam,Amsterdam,The Netherlands.

H Nazir (H)

Human Development Research Foundation,Islamabad,Pakistan.

P Akhtar (P)

Human Development Research Foundation,Islamabad,Pakistan.

A Masood (A)

Human Development Research Foundation,Islamabad,Pakistan.

D Wang (D)

Liverpool School of Tropical Medicine,Liverpool,UK.

E Wang (E)

Queen Mary University of London,UK.

I Uddin (I)

Bacha Khan Medical College,Mardan,Pakistan.

M van Ommeren (M)

Department of Mental Health and Substance Abuse,World Health Organisation,Geneva,Switzerland.

A Rahman (A)

Human Development Research Foundation,Islamabad,Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH